Core Insights - Sustainable Green Team, Ltd. (SGTM) has launched its Water Less Garden soil on Amazon, marking a significant step in making eco-friendly gardening solutions widely accessible [1][4] - The U.S. soil market is substantial, with 300 million bags sold annually, catering to 42 million gardening households, indicating a strong demand for sustainable products [2] - Water Less Garden is a 100% organic and chemical-free soil amendment that retains up to 90% of its weight in moisture, promoting healthier plants with reduced watering needs [2][5] Company Overview - SGTM is positioned as a leader in eco-innovative soil and waste-to-wealth technologies, focusing on transforming waste into valuable products [1][5] - The company has evolved from a mulch and soil wholesaler to a technology-driven entity dedicated to environmental restoration [4] - Upcoming product launches include Living Mulch, Deer Soil, and the Soil Concentrate™ Kit, alongside a blockchain tracking and reward platform [4][5] Market Context - The timing for the introduction of Water Less Garden is optimal, given the increasing need for sustainable gardening solutions across the U.S. [2] - The product is designed to address the needs of over 50 million acres of turf grass, emphasizing smarter and sustainable care [2] Media Presence - Water Less Garden has gained media attention, being featured on platforms like Fox Business and Bloomberg, highlighting its significance as a movement towards sustainable gardening [3]

Terrestrial Energy begins trading today under the new ticker symbol “IMSR” after completing its business combination with HCM II Acquisition Corp. Terrestrial Energy received in excess of $292 million of gross transaction proceeds, before expenses, to support its business plan and accelerate technology commercialization Terrestrial Energy’s Integral Molten Salt Reactor (IMSR) nuclear plants are designed to supply low-cost high-temperature, clean, firm and flexible heat and electricity, delivering sector-lea ...

Core Insights - HeartCore Enterprises, Inc. has authorized a one-time payment of $0.13 per share to its stockholders, which will be classified as a distribution for U.S. federal tax purposes rather than a dividend [1] - The record date for stockholders to participate in this distribution is November 10, 2025, with the payment date set for November 17, 2025 [2] - The distribution payment of $0.13 per share represents approximately 16.8% of the company's stock price as of October 27, 2025 [2] Company Overview - HeartCore Enterprises, Inc. is headquartered in Tokyo, Japan, with additional offices in New York and San Francisco, CA, and specializes in enterprise software and consulting services [3] - The company offers Software as a Service (SaaS) solutions and data analytics services aimed at enhancing customer experiences for enterprise clients [3][4] - HeartCore's customer experience management platform includes various systems for marketing, sales, service, and content management, along with tools for digital transformation such as robotics process automation [4] Consulting Services - HeartCore provides a Go IPOSM consulting service that assists Japanese-based companies in going public in the U.S. [5]

Core Insights - ProPhase Labs has published a peer-reviewed study demonstrating the effectiveness of its BE-Smart assay for identifying patients at risk of progressing from Barrett's Esophagus to esophageal adenocarcinoma, achieving 100% sensitivity in detecting such patients [1][5] - The BE-Smart assay is positioned as a next-generation molecular screening tool, ready for clinical adoption and reimbursement discussions, with early access programs expected to begin in early 2026 [2][6] Group 1: Study Findings - The BE-Smart assay utilizes an 8-protein mass-spectrometry-based approach, requiring significantly less tissue than traditional assays, and is compatible with various biopsy methods [3][4] - The assay demonstrated strong predictive performance with an overall area under the curve (AUC) of 0.75, and an AUC of 0.89 in an independent test cohort, indicating high diagnostic accuracy [5] - A hazard ratio of 66.1 indicates that patients classified as high-risk by BE-Smart are approximately 66 times more likely to progress to esophageal cancer compared to low-risk patients [5] Group 2: Clinical Implications - The greatest clinical benefit of BE-Smart is observed in patients with non-dysplastic Barrett's Esophagus, providing clear molecular risk stratification where traditional histopathology offers limited insight [5] - The assay aims to enable earlier identification of at-risk patients, potentially improving outcomes through precision screening, addressing the challenge of late-stage diagnosis in esophageal cancer [7] Group 3: Company Strategy - ProPhase Labs is advancing BE-Smart towards broad commercialization, focusing on laboratory partnerships, payer engagement, and expanded real-world studies in collaboration with gastroenterology networks [6] - The company emphasizes its commitment to innovation in healthcare, with BE-Smart being part of its precision oncology pipeline [8][9]

JACKSONVILLE, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- CSX (NASDAQ: CSX) today announced executive leadership changes designed to strengthen the company’s strategic focus and advance its long-term growth objectives. Effective immediately, Kevin Boone has been named executive vice president and chief financial officer, succeeding Sean Pelkey, who has departed the company. Maryclare Kenney has been promoted to senior vice president and chief commercial officer, reinforcing the company’s commitment to driving c ...

The fixed-rate loan is available now through December 31, with enhanced features and flexible repayment optionsKANSAS CITY, Miss., Oct. 29, 2025 (GLOBE NEWSWIRE) -- H&R Block (NYSE: HRB) today announced the 2025 application period for the Emerald Advance® Loan1, a fixed-rate short-term loan ranging from $350 to $1,500, available November 3 through December 31, 2025. “The goal is to reduce financial stress and bring more joy to the season, and the loan application process is convenient and accessible,” said ...

The Harbinger Report Outlines The Firm's Independent Estimates For Significant Revenue Growth In The Coming Years Harbinger Research Initiates Coverage, Highlighting Powerful Dual Revenue Engine, Deflationary Asset Strategy, And Unique Opportunity On Nasdaq SCOTTSDALE, Ariz., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Bonk, Inc. (Nasdaq: BNKK) (the “Company”), which holds a treasury of the $BONK cryptocurrency token built on the Solana blockchain, focused on empowering a community building revenue generating product ...

This article has been disseminated on behalf of LaFleur Minerals, and it may include a paid advertisement. NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- via InvestorWire — LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 75+ brands within the Dynamic Brand Portfolio@IBN (InvestorBrandNetwork), a specialized communications platform with a focus on financial news and content distribution for private and public companies ...

Core Points - Houston American Energy Corp. (HUSA) has commenced construction on Phase One of its Cedar Port development plan in Baytown, Texas, which includes the Abundia Innovation Center and the R&D Facility [1][2][5] - The Abundia Innovation Center will function as a collaborative office and technology hub, while the R&D Facility will focus on advanced laboratories and pilot-scale systems for waste-to-fuels technologies [4][5] - Completion of Phase One is targeted for Q2-2026, with future phases planned to include an advanced plastics recycling facility [5] Company Overview - HUSA is an independent energy company with a diversified portfolio in both conventional and renewable sectors, having recently acquired Abundia Global Impact Group (AGIG) to enhance its capabilities in converting waste plastics into low-carbon fuels [6] - The strategic acquisition of AGIG reflects HUSA's commitment to addressing global energy demands through a mix of traditional and alternative energy solutions [6]

COPENHAGEN, Denmark, October 29, 2025 – Pursuant to section 30 of the Danish Capital Markets Act, Bavarian Nordic A/S hereby announces that the Company has received notification from Morgan Stanley that they hold 5.20% of the shares and voting rights in Bavarian Nordic A/S as of October 23, 2025. About Bavarian NordicBavarian Nordic is a global vaccine company with a mission to improve health and save lives through innovative vaccines. We are a preferred supplier of mpox and smallpox vaccines to government ...